[ Network menu | Network entry | Help ]

ENTRY	nt06262
Name	Pancreatic cancer
Category	Disease view; Cancer
Pathway	hsa05212 Pancreatic cancer
Disease	H00019 Pancreatic cancer
Display	drug-target relation   disease type

ERK signaling N00216    HGF → MET → GRB2 → SOS → RAS → RAF → MEK → ERK N00012                    (KRAS*,NRAS*) → RAF → MEK → ERK → CCND1   Other RAS signaling N00103    EGF → EGFR → GRB2 → SOS → RAS → RALGDS → RAL N00104                    KRAS* → RALGDS → RAL   PI3K signaling N00284                AREG → EGFR → PI3K → PIP3 → AKT → MTOR → S6K N00034                EGF → (ERBB2*+EGFR) → PI3K → PIP3 → AKT → MTOR → S6K N00218    FLT3LG → FLT3 → GRB2 → SOS → RAS → PI3K → PIP3 → AKT → MTOR N00032                    (KRAS*,NRAS*) → PI3K → PIP3 → AKT ⊣ BAD   JAK-STAT signaling N00094    EGF → EGFR → JAK1 → STAT1/3/5 N00095    EGF → (ERBB2*+EGFR) → JAK1 → STAT1/3 ⇒ VEGFA   Cell cycle N00069    CDKN2A ⊣ (CCND+CDK4/6) → RB1 ⌿ E2F N00070    CDKN2A* ⌿ (CCND+CDK4/6) → RB1 ⌿ E2F N00071    CDKN2A* ⌿ (CCND+CDK4/6) → RB1 ⌿ E2F   Transcription N00115    TP53* ⌿ (CDKN1A,GADD45,BAX..

		Drug name
D1	D11991	Zenocutuzumab (USAN/INN)